Article
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
Human molecular genetics - 15 Oct 2008
Stum Morgane, Girard Emmanuelle, Bangratz Marie, Bernard Véronique, Herbin Marc, Vignaud Alban, Ferry Arnaud, Davoine Claire-Sophie, Echaniz-Laguna Andoni, René Frédérique, Marcel Christophe, Molgó Jordi, Fontaine Bertrand, Krejci Eric, Nicole Sophie
Abstract excerpt
Schwartz-Jampel syndrome (SJS) is a recessive neuromyotonia with chondrodysplasia. It results from hypomorphic mutations of the gene encoding perlecan, leading to a decrease in the levels of this heparan sulphate proteoglycan in basement membranes (BMs). It has been suggested that SJS neuromyotonia may result from endplate acetylcholinesterase (AChE) deficiency, but this hypothesis has never been investigated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
